Risk Factors Associated With Hyperammonemia Following Unprovoked Convulsive Seizures.

convulsive seizures hyperammonemia metabolism neurophysiology

Journal

Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737

Informations de publication

Date de publication:
08 Jun 2020
Historique:
entrez: 14 7 2020
pubmed: 14 7 2020
medline: 14 7 2020
Statut: epublish

Résumé

This report describes a unique case of recurrent transient hyperammonemia (THA) following a first-time occurrence of generalized tonic-clonic seizure in a young adult, who went on to develop post-stroke epilepsy. Although this phenomenon has been described in recent literature, we report not only the highest initial ammonia level to date, 549 µmol/L, but we also document serial trends of the ammonia levels at multiple admissions for the same patient for the management of breakthrough seizures. Interestingly enough, persistence of the elevation of the ammonia levels was accompanied by no other significant metabolic derangements, unlike reported in similar cases. Of prior studies, high ammonia levels have been reported in the context of alcohol-induced seizures, with resolution of ammonia levels within eight hours. Here, we highlight the importance of medication compliance, as well as the need for serial ammonia levels for improving patient outcomes, with the knowledge that ammonia accumulation leads to potential irreversible neurotoxicity. Additionally, we completed a systematic literature review on data pertaining to the risk factors associated with hyperammonemia following unprovoked convulsive seizures in an effort to analyze our case in the context of the existing literature. Our objective is to ultimately understand the utility of serial ammonia levels for unprovoked convulsive seizures in the context of the patient's initial presentation, and whether treatment of these episodes of hyperammonemia can significantly alter outcomes.

Identifiants

pubmed: 32656020
doi: 10.7759/cureus.8504
pmc: PMC7346305
doi:

Types de publication

Case Reports

Langues

eng

Pagination

e8504

Informations de copyright

Copyright © 2020, Karim et al.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Nat Clin Pract Urol. 2007 Aug;4(8):455-8
pubmed: 17673917
PLoS Med. 2009 Jul 21;6(7):e1000097
pubmed: 19621072
Seizure. 2016 Dec;43:6-12
pubmed: 27768938
Intern Med. 2008;47(1):21-3
pubmed: 18176000
Am J Emerg Med. 2013 Oct;31(10):1486-9
pubmed: 24007697
Am J Physiol Endocrinol Metab. 2012 Oct 15;303(8):E983-93
pubmed: 22895779
Arch Neurol. 1970 Aug;23(2):155-60
pubmed: 5430334
Compr Physiol. 2013 Jan;3(1):201-20
pubmed: 23720285
Neurology. 2005 Sep 13;65(5):668-75
pubmed: 16157897
Epilepsia. 2011 Nov;52(11):2043-9
pubmed: 21972984
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18162-7
pubmed: 24145431
Intern Med. 2011;50(20):2297-301
pubmed: 22001454
Nat Rev Cancer. 2003 May;3(5):330-8
pubmed: 12724731
Arch Neurol. 1985 Feb;42(2):123-6
pubmed: 3977637
J Physiol. 2016 Dec 15;594(24):7341-7360
pubmed: 27558544
Eur Neurol. 2010;64(1):46-50
pubmed: 20606448

Auteurs

Nurose Karim (N)

Neurology, University of Toledo Medical Center, Toledo, USA.

Giana Dawod (G)

Neurology, University of Toledo Medical Center, Toledo, USA.

Nicholas D Henkel (ND)

Neurology, University of Toledo Medical Center, Toledo, USA.
Neurology, University of Toledo College of Medicine, Toledo, USA.

Ajaz A Sheikh (AA)

Neurology, University of Toledo Medical Center, Toledo, USA.

Classifications MeSH